J Clin Med Res
Journal of Clinical Medicine Research, ISSN 1918-3003 print, 1918-3011 online, Open Access
Article copyright, the authors; Journal compilation copyright, J Clin Med Res and Elmer Press Inc
Journal website http://www.jocmr.org

Case Report

Volume 3, Number 5, October 2011, pages 275-277


Multiple Systemic Infarctions as a Complication of Bronchial Artery Embolization With Polyvinyl Alcohol: A Case Report

Abdullah Ozkoka, c, Ayse Serra Ucara, Timur Selcuk Akpinara, Gulfer Okumusb, Esen Kiyanb, Orhan Arsevenb

aIstanbul Faculty of Medicine, Department of Internal Medicine, Istanbul University, Istanbul, Turkey
bIstanbul Faculty of Medicine, Department of Chest Medicine, Istanbul University, Istanbul, Turkey
cCorresponding author: Abdullah Ozkok, Istanbul Faculty of Medicine, Department of Internal Medicine, Istanbul University, 34390, Fatih/Istanbul/Turkey

Manuscript accepted for publication August 16, 2011
Short title: Bronchial Artery Embolization With Polyvinyl Alcohol
doi: https://doi.org/10.4021/jocmr665w

Abstract▴Top 

Bronchial artery embolization (BAE) is a widely used modality of treatment for massive hemoptysis which has well known complications such as chest pain, groin hematoma and transverse myelitis but systemic embolization of the material used in the procedure is very rare and was reported only four times in the literature which were all caused by the use of microspheres. Herein we report a case of a 41-year-old caucasian male who had a history of tuberculosis 10 years ago. He had BAE with polyvinyl alcohol (PVA) for the treatment of recurrent hemoptysis. After the procedure, the patient complained of severe pain on the left upper quadrant and bilateral costovertebral regions and in abdominal CT, multiple infarcts in the subcapsular area of the spleen and kidneys were observed. This is the first reported case of inadvertent systemic embolization secondary to BAE with PVA. Although the risk of systemic embolization is greater with microspheres, still potentially serious and life threatening complications may occur with PVA.

Keywords: Bronchial artery emobolization; Complication; Polyvinyl alcohol

Introduction▴Top 

Bronchial artery embolization (BAE) is a well-accepted and effective form of treatment for massive and recurrent hemoptysis but some potentially life threatening complications including organ infarcts due to inadverent systemic embolization of material used in the procedure may occur. We present a case of multiple infarcts in the spleen and kidneys secondary to bronchial artery embolization with polyvinyl alcohol (PVA).

Case Presentation▴Top 

A 41-year-old caucasian male who had a history of tuberculosis 10 years ago was referred to our clinic for BAE for the treatment of recurrent hemoptysis of 30-50 cc per day for the last 3 months. Thorax and abdominal CT were performed for the suspicion of a malignancy. Abdominal CT was totally normal (Fig. 1) and thorax CT demonstrated only fibrotic sequels and bronchiectatic lesions in the apical segment of the right upper lobe and pleuroparenchymal sequel band formations in the superior segment of the right lower lobe and no sign of a malignancy. The source of the hemoptysis was considered to be these sequel lesions secondary to past pulmonary tuberculosis.

Figure 1.
Click for large image
Figure 1. Abdominal CT is completely normal before the bronchial artery embolization.
Discussion▴Top 

BAE has various reported complications which may be severe and life threatening such as spinal cord infarction, transverse myelitis [1], myocardial infarction [2], serebrovascular accident [2-4], splenic and renal infarcts [3], esophagobronchial fistula [5], diaphragmatic paralysis [6], infarction of the bronchus [7], subintimal dissection of aorta [1,8], arterial perforation [8], mediastinal hematoma [1], or mild and self-limited such as chest pain [1,8], shoulder pain [8], transient dysphagia [8,9], transient cortical blindness [10], transient left orbital and forehead pain [9] and groin hematoma [8].

Systemic embolization during BAE is a very rare complication and to our knowledge there are only four reported cases including infarcts in the spleen and kidneys, myocardial infarction and serebrovascular accident [2-4]. Embolization materials used in these reports were microspheres. Our case is the first report of systemic embolization due to BAE with PVA.

We postulate that PVA had traversed from the bronchial circulation into the pulmonary circulation and then into small pulmonary arteriovenous malformations, and finally into the systemic circulation causing multiple infarcts in the spleen and both kidneys.

Actually, the risk of systemic embolization is higher with microspheres when compared with PVA because PVA has variability in size and a tendency to aggregate. These properties limit the ability to embolize peripheral vessels and cross arteriovenous anastomoses; however, microspheres do not have these limitations [3].

Conclusion

We have presented the first case of inadvertent systemic embolization secondary to BAE with PVA. Although the risk of systemic embolization is greater with microspheres, still potentially serious and life threatening complications may occur with PVA.


References▴Top 
  1. Mal H, Rullon I, Mellot F, Brugiere O, Sleiman C, Menu Y, Fournier M. Immediate and long-term results of bronchial artery embolization for life-threatening hemoptysis. Chest. 1999;115(4):996-1001.
    pubmed
  2. Vinaya KN, White RI, Jr . , Sloan JM. Reassessing bronchial artery embolotherapy with newer spherical embolic materials. J Vasc Interv Radiol. 2004;15(3):304-305.
    pubmed
  3. Sriram KB, Taylor DJ, Holmes M. Systemic multifocal infarction following bronchial artery embolization with microsphere particles. Intern Med J. 2007;37(10):734-735.
    pubmed
  4. FitzGerald DB, Suran EL, Sargent J. Posterior circulation infarct after bronchial artery embolization and coiling. Neurology. 2005;65(8):
    pubmed
  5. Hsu HK, Su JM. Giant bronchoesophageal fistula: a rare complication of bronchial artery embolization. Ann Thorac Surg. 1995;60(6):1797-1798.
    pubmed
  6. Chapman SA, Holmes MD, Taylor DJ. Unilateral diaphragmatic paralysis following bronchial artery embolization for hemoptysis. Chest. 2000;118(1):269-270.
    pubmed
  7. Ivanick MJ, Thorwarth W, Donohue J, Mandell V, Delany D, Jaques PF. Infarction of the left main-stem bronchus: a complication of bronchial artery embolization. AJR Am J Roentgenol. 1983;141(3):535-537.
    pubmed
  8. Swanson KL, Johnson CM, Prakash UB, McKusick MA, Andrews JC, Stanson AW. Bronchial artery embolization : experience with 54 patients. Chest. 2002;121(3):789-795.
    pubmed
  9. Ramakantan R, Bandekar VG, Gandhi MS, Aulakh BG, Deshmukh HL. Massive hemoptysis due to pulmonary tuberculosis: control with bronchial artery embolization. Radiology. 1996;200(3):691-694.
    pubmed
  10. Liu SF, Lee TY, Wong SL, Lai YF, Lin AS. Transient cortical blindness: a complication of bronchial artery embolization. Respir Med. 1998;92(7):983-986.
    pubmed


This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.


Journal of Clinical Medicine Research is published by Elmer Press Inc.

 

Browse  Journals  

 

Journal of Clinical Medicine Research

Journal of Endocrinology and Metabolism

Journal of Clinical Gynecology and Obstetrics

 

World Journal of Oncology

Gastroenterology Research

Journal of Hematology

 

Journal of Medical Cases

Journal of Current Surgery

Clinical Infection and Immunity

 

Cardiology Research

World Journal of Nephrology and Urology

Cellular and Molecular Medicine Research

 

Journal of Neurology Research

International Journal of Clinical Pediatrics

 

 
       
 

Journal of Clinical Medicine Research, monthly, ISSN 1918-3003 (print), 1918-3011 (online), published by Elmer Press Inc.                     
The content of this site is intended for health care professionals.
This is an open-access journal distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License, which permits unrestricted
non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.
Creative Commons Attribution license (Attribution-NonCommercial 4.0 International CC-BY-NC 4.0)


This journal follows the International Committee of Medical Journal Editors (ICMJE) recommendations for manuscripts submitted to biomedical journals,
the Committee on Publication Ethics (COPE) guidelines, and the Principles of Transparency and Best Practice in Scholarly Publishing.

website: www.jocmr.org   editorial contact: editor@jocmr.org
Address: 9225 Leslie Street, Suite 201, Richmond Hill, Ontario, L4B 3H6, Canada

© Elmer Press Inc. All Rights Reserved.


Disclaimer: The views and opinions expressed in the published articles are those of the authors and do not necessarily reflect the views or opinions of the editors and Elmer Press Inc. This website is provided for medical research and informational purposes only and does not constitute any medical advice or professional services. The information provided in this journal should not be used for diagnosis and treatment, those seeking medical advice should always consult with a licensed physician.